BioMarin也迅速跟进迭代研发，其升级版在研产品BMN333同样旨在实现周剂注射。早期临床结果显示BMN333的AUC水平高于其他长效CNP研究的3倍以上，公司研发主管Greg Friberg表示该药对标的正是TransCon-CNP。
Opus First Contact#With my AGENTS.md file set up, I did more research into proper methods of prompting agents to see if I was missing something that led to the poor performance from working with Sonnet 4.5.
，推荐阅读旺商聊官方下载获取更多信息
Copyright © 1997-2026 by www.people.com.cn all rights reserved
Get editor selected deals texted right to your phone!